CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)
Close on Nov 18, 2026Market cap $21.92MP/E –Yield –
CervoMed gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2013 it was 100.0%, against 37.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | 100.0% | +63.0 |
| FY2012 | Dec 31, 2012 | 37.0% | +341.7 |
| FY2011 | Dec 31, 2011 | -304.7% | +118.8 |
| FY2010 | Dec 31, 2010 | -423.5% | – |
See a number that looks wrong?